Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Supernus Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 334
- +11 vs. Q1 2026
- Shares held
- 60.2M
- +2.05M (+3.5%) vs. Q1 2026
- Total value
- $2.80B
- −$205.5M (−6.8%) vs. Q1 2026
- New holders
- 46
- 119 more added
- Sold out
- 35
- 114 more reduced
5 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SUPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 334 | $2.80B |
| Q1 2026 | 328 | $3.01B |
| Q4 2025 | 333 | $2.84B |
| Q3 2025 | 310 | $2.76B |
| Q2 2025 | 295 | $1.87B |
| Q1 2025 | 295 | $1.94B |
| Q4 2024 | 294 | $2.15B |
| Q3 2024 | 273 | $1.87B |
| Q2 2024 | 245 | $1.56B |
| Q1 2024 | 251 | $1.93B |
| Q4 2023 | 245 | $1.65B |
| Q3 2023 | 239 | $1.57B |
| Q2 2023 | 249 | $1.72B |
| Q1 2023 | 259 | $2.01B |
| Q4 2022 | 264 | $1.99B |
| Q3 2022 | 244 | $1.88B |
| Q2 2022 | 225 | $1.58B |
| Q1 2022 | 230 | $1.75B |
| Q4 2021 | 235 | $1.61B |
| Q3 2021 | 224 | $1.45B |
| Q2 2021 | 226 | $1.67B |
| Q1 2021 | 224 | $1.40B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Supernus Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 377,402 | $17.6M | 0.00% | +14,994+4.1% | Added |
| Vanguard Fiduciary Trust Co | 384,828 | $17.9M | 0.00% | +15,581+4.2% | Added |
| Victory Capital Management Inc | 391,075 | $18.2M | 0.01% | −111,331−22.2% | Reduced |
| Invesco Ltd. | 395,101 | $18.4M | 0.00% | −17,582−4.3% | Reduced |
| Pictet Asset Management Holding SA | 432,478 | $20.2M | 0.02% | −18,286−4.1% | Reduced |
| Standard Life Aberdeen plc | 453,206 | $21.1M | 0.03% | +177,645+64.5% | Added |
| Systematic Financial Management LP | 474,131 | $22.1M | 0.44% | +98,052+26.1% | Added |
| Rice Hall James & Associates, LLC | 490,221 | $22.8M | 1.11% | +12,805+2.7% | Added |
| Soleus Capital Management, L.P. | 520,000 | $24.2M | 0.83% | +520,000 | New |
| Ashford Capital Management Inc | 613,783 | $28.5M | 3.06% | −31,598−4.9% | Reduced |
| Bank of America Corp | 621,102 | $28.9M | 0.00% | −93,124−13.0% | Reduced |
| Charles Schwab Investment Management Inc | 703,552 | $32.7M | 0.00% | −2,424−0.3% | Reduced |
| Woodline Partners LP | 708,276 | $32.9M | 0.10% | +259,280+57.7% | Added |
| Northern Trust Corp | 733,374 | $34.1M | 0.00% | +33,918+4.8% | Added |
| D. E. Shaw & Co., Inc. | 767,668 | $35.7M | 0.02% | +145,218+23.3% | Added |
| Goldman Sachs Group Inc | 819,432 | $38.1M | 0.00% | −37,055−4.3% | Reduced |
| Morgan Stanley | 876,841 | $40.8M | 0.00% | −37,052−4.1% | Reduced |
| Qube Research & Technologies Ltd | 922,166 | $42.9M | 0.05% | +423,968+85.1% | Added |
| Sofinnova Investments, Inc. | 1,036,328 | $48.2M | 2.57% | +82,019+8.6% | Added |
| GW&K Investment Management, LLC | 1,037,242 | $48.2M | 0.38% | −17,942−1.7% | Reduced |
| Two Sigma Investments, LP | 1,184,378 | $55.1M | 0.04% | +913,150+336.7% | Added |
| Citadel Advisors LLC | 1,373,982 | $63.9M | 0.04% | −119,464−8.0% | Reduced |
| Loomis Sayles & Co L P | 1,475,192 | $68.6M | 0.09% | +49,413+3.5% | Added |
| Renaissance Technologies LLC | 1,478,180 | $68.8M | 0.09% | −227,042−13.3% | Reduced |
| Stephens Investment Management Group LLC | 1,485,821 | $69.1M | 0.74% | +134,490+10.0% | Added |
| Geode Capital Management, LLC | 1,570,088 | $73.0M | 0.00% | −53,426−3.3% | Reduced |
| Dimensional Fund Advisors LP | 2,078,090 | $96.7M | 0.02% | −228,940−9.9% | Reduced |
| Nomura Asset Management International Inc. | 2,378,329 | $110.6M | 0.17% | +341,127+16.7% | Added |
| State Street Corp | 2,459,828 | $114.4M | 0.00% | +171,701+7.5% | Added |
| Vanguard Capital Management LLC | 2,516,721 | $117.1M | 0.00% | +49,506+2.0% | Added |
| Armistice Capital, LLC | 2,646,201 | $123.1M | 3.40% | +750,854+39.6% | Added |
| Vanguard Portfolio Management LLC | 3,305,429 | $153.7M | 0.01% | +66,736+2.1% | Added |
| Millennium Management LLC | 3,853,212 | $179.2M | 0.12% | +537,239+16.2% | Added |
| BlackRock, Inc. | 9,350,046 | $434.9M | 0.01% | +552,792+6.3% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −1,318,555−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −90,821−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −85,200−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −85,062−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −66,000−100.0% | Sold out |
| Catalio Capital Management, LP | 0 | $0 | 0.00% | −62,019−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −57,327−100.0% | Sold out |
| Westover Capital Advisors, LLC | 0 | $0 | 0.00% | −31,998−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,976−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −11,501−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −11,214−100.0% | Sold out |
| Perbak Capital Partners LLP | 0 | $0 | 0.00% | −6,754−100.0% | Sold out |
| Verdad Advisers, LP | 0 | $0 | 0.00% | −6,295−100.0% | Sold out |
| Contravisory Investment Management, Inc. | 0 | $0 | 0.00% | −5,981−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −5,107−100.0% | Sold out |
| SmartHarvest Portfolios, LLC | 0 | $0 | 0.00% | −4,918−100.0% | Sold out |
| Fieldview Capital Management, LLC | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −4,419−100.0% | Sold out |
| Claro Advisors LLC | 0 | $0 | 0.00% | −4,275−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −4,099−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −399−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −287−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −171−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Legacy Wealth Managment, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Abound Wealth Management | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Dunhill Financial, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| Journey Strategic Wealth LLC | – | – | – | – | Not filed |
| Skopos Labs, Inc. | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |